A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00866333 Information provided by Syndax Pharmaceuticals

First Received: March 19, 2009 Last Updated: July 29, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2012
Estimated Primary Completion Date:	July 2011 (Final data collection date for primary outcome measure)